TATEMENT OF FRESENIUS MEDICAL CARE NORTH AMERICA REGARDING CENTERS FOR MEDICARE & MEDICAID SERVICES REQUEST FOR INFORMATION
WALTHAM, Mass. — August 19, 2016 — In response to the Centers for Medicare & Medicaid Services’ (CMS) recent Request for Information, Fresenius Medical Care North America issued the following statement:
“We welcome the opportunity to provide information in support of CMS’ effort to maintain and enhance a sustainable and responsible system for the benefit of patients. We do not operate the kind of program that CMS highlighted in the Request for Information to steer patients receiving Medicaid benefits into exchange plans.”
“Too many Americans with kidney failure are unable to obtain and afford health coverage of their choice. With the assistance of charities like the American Kidney Fund, those in need are able to gain access to coverage that is readily available to most other Americans, including coverage in exchange plans. We look forward to working with CMS, insurers and the community to put in place any reforms that are necessary to ensure that charities like the AKF can continue their important work and avoid abuses that could threaten the viability and sustainability of exchange plans.”
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs, and urgent care centers, as well as the country’s largest practice of hospitalist and post-acute providers, Fresenius Medical Care provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at www.freseniusmedicalcare.us. For information about patient services, visit www.freseniuskidneycare.com.
Media Contact:
Fresenius Medical Care North America
Robert Sepucha
Robert.Sepucha@fmc-na.com
Office: 781-699-4028
Cell: 781-472-975
